Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

@article{Diazgranados2014EfficacyOH,
  title={Efficacy of high-dose versus standard-dose influenza vaccine in older adults.},
  author={C. Diazgranados and A. Dunning and M. Kimmel and D. Kirby and J. Treanor and Avi Collins and R. Pollak and Janet Christoff and John Earl and Victoria A Landolfi and E. Martin and S. Gurunathan and Richard Nathan and D. Greenberg and Nadia G. Tornieporth and M. Decker and H. Talbot},
  journal={The New England journal of medicine},
  year={2014},
  volume={371 7},
  pages={
          635-45
        }
}
  • C. Diazgranados, A. Dunning, +14 authors H. Talbot
  • Published 2014
  • Medicine
  • The New England journal of medicine
  • BACKGROUND As compared with a standard-dose vaccine, a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD) improves antibody responses to influenza among adults 65 years of age or older. This study evaluated whether IIV3-HD also improves protection against laboratory-confirmed influenza illness. METHODS We conducted a phase IIIb-IV, multicenter, randomized, double-blind, active-controlled trial to compare IIV3-HD (60 μg of hemagglutinin per strain) with standard-dose trivalent… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Adjuvanted flu vaccine, Fluad, is not immunologically inferior to HD influenza vaccine in older persons living in long-term care.  
    ConditionsFlu
    InterventionDrug

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 42 REFERENCES